Get started
Ono Pharmaceutical Co., Ltd.Ono Pharmaceutical Co., Ltd.Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd.

No trades
See on Supercharts
OverviewFinancialsNewsDiscussionsTechnicalsForecastSeasonals

OPHLY chart


Full chart

OPHLY upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪5.35 B‬ USD
Dividend yield (indicated)
2.93%
Price to earnings Ratio (TTM)
18.16
Basic EPS (TTM)
0.21 USD
Net income (FY)
‪328.28 M‬ USD
Revenue (FY)
‪3.19 B‬ USD
Shares float
—
Beta (1Y)
−0.19

About ONO Pharmaceutical Co., Ltd.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Gyo Sagara
Website
ono.co.jp
Headquarters
Osaka
Founded
1947
ISIN
US6827361030
FIGI
BBG000G1QMG5
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.

Check out other big names from the same industry as OPHLY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

OPHLY news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.